{
    "organizations": [],
    "uuid": "b389b68ae25a423d1b333614b77d1cb4b71b9776",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-microport-scientific-corp-sees-30/brief-microport-scientific-corp-sees-30-to-35-increase-in-profit-attributable-for-fy2017-idUSFWN1QI14L",
    "ord_in_thread": 0,
    "title": "BRIEF-Microport Scientific Corp Sees 30% To 35% Increase In Profit Attributable For FY2017",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Microport Scientific Corp:\n* SEES 30% TO 35% INCREASE IN PROFIT ATTRIBUTABLE TO EQUITY SHAREHOLDERS OF COMPANY FOR YEAR ENDED 31 DECEMBER 2017\n* INCREASE PROFIT ATTRIBUTABLE DUE TO GROWTH IN REVENUE FROM CARDIOVASCULAR AND ENDOVASCULAR SEGMENTS IN PRC MARKET Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-28T22:10:00.000+02:00",
    "crawled": "2018-03-01T21:11:07.016+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "microport",
        "scientific",
        "corp",
        "see",
        "increase",
        "profit",
        "attributable",
        "equity",
        "shareholder",
        "company",
        "year",
        "ended",
        "december",
        "increase",
        "profit",
        "attributable",
        "due",
        "growth",
        "revenue",
        "cardiovascular",
        "endovascular",
        "segment",
        "prc",
        "market",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}